B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells

被引:8
|
作者
Secreto, Frank [1 ]
Manske, Michelle [1 ]
Price-Troska, Tammy [1 ]
Ziesmer, Steven [1 ]
Hodge, Lucy S. [1 ]
Ansell, Stephen M. [1 ]
Cerhan, James R. [2 ]
Novak, Anne J. [1 ]
机构
[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
[2] Mayo Clin, Div Epidemiol, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
BAFF-R; BAFF; lymphoma; PI3K; NF-KAPPA-B; NON-HODGKIN-LYMPHOMA; PROLYL ISOMERASE PIN1; BAFF-R; INDEPENDENT PATHWAY; TNF RECEPTOR; EXPRESSION; FAMILY; BLYS; SURVIVAL;
D O I
10.3109/10428194.2013.862619
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B-cell activating factor-receptor (BAFF-R) is the primary BAFF receptor that is responsible for promoting B-cell development and survival. Malignant B-cells exploit the BAFF/BAFF-R system, and high serum BAFF levels or genetic alterations in BAFF receptors have been found in B-cell cancers. BAFF signaling impacts pro-survival pathways. However, other than nuclear factor-kappa B2 (NF-kappa B2), little is known about the specific pathways activated by individual BAFF receptors. Using a novel BAFF-R expression model we have demonstrated that activation of BAFF-R, independent of transmembrane activator and cytophilin ligand interactor (TACI) and B-cell maturation antigen (BCMA), can induce phosphorylation of Akt and glycogen synthase kinase 3 beta (GSK3 beta). Expression of an activated form of BAFF-R also enhanced a pro-survival gene expression pattern, including the novel BAFF-regulated gene Pin1, whose expression was phosphatidyl inositol 3-kinase (PI3K)-dependent. Additionally, we showed that TRAF6 is essential for mediating BAFF-R dependent activation of Akt. Together these data describe a novel role for TRAF6 in BAFF-R-specific activation of the PI3K pathway and provide evidence suggesting a new role for Pin1 in BAFF-R signaling.
引用
收藏
页码:1884 / 1892
页数:9
相关论文
共 50 条
  • [31] Constitutive activation of alternative nuclear factor kappa B pathway in canine diffuse large B-cell lymphoma contributes to tumor cell survival and is a target of new adjuvant therapies
    Seelig, Davis M.
    Ito, Daisuke
    Forster, Colleen L.
    Yoon, Una A.
    Breen, Matthew
    Burns, Linda J.
    Bachanova, Veronika
    Lindblad-Toh, Kerstin
    O'Brien, Timothy D.
    Schmechel, Stephen C.
    Rizzardi, Anthony E.
    Modiano, Jaime F.
    Linden, Michael A.
    LEUKEMIA & LYMPHOMA, 2017, 58 (07) : 1702 - 1710
  • [32] Increased gene expression of B cell-activating factor of tumor necrosis factor family, in remitting antineutrophil cytoplasmic antibody-associated vasculitis patients
    Jha, Saket
    Singh, Jagdeep
    Minz, Ranjana W.
    Dhooria, Aadhar
    Naidu, G. S. R. S. N. K.
    Kumar, Rajiv Ranjan
    Rathi, Manish
    Jain, Sanjay
    Anand, Shashi
    Sharma, Aman
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (02) : 218 - 227
  • [33] Serum Soluble Tumor Necrosis Factor Receptor 1 Level is Associated with the Outcome of Diffuse Large B-Cell Lymphoma Patients Treated with the CHOP or R-CHOP Regimen
    Goto, Naoe
    Tsurumi, Hisashi
    Takemura, Masao
    Matsumoto, Takuro
    Shibata, Yuhei
    Mabuchi, Ryoko
    Nakamura, Nobuhiko
    Nakamura, Hiroshi
    Yamada, Tetsuya
    Seishima, Mitsuru
    Takami, Tsuyoshi
    Takeuchi, Tamotsu
    Moriwaki, Hisataka
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2014, 54 (02) : 117 - 127
  • [34] Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions
    Hildebrand, Joanne M.
    Yi, Zuoan
    Buchta, Claire M.
    Poovassery, Jayakumar
    Stunz, Laura L.
    Bishop, Gail A.
    IMMUNOLOGICAL REVIEWS, 2011, 244 : 55 - 74
  • [35] Suppression of tumor cell proliferation by quinine via the inhibition of the tumor necrosis factor receptor-associated factor 6-AKT interaction
    Liu, Wenjuan
    Qi, Yonghao
    Liu, Lingyu
    Tang, Yu
    Wei, Jing
    Zhou, Lijun
    MOLECULAR MEDICINE REPORTS, 2016, 14 (03) : 2171 - 2179
  • [36] Bruton's tyrosine kinase mediates NF-κB activation and B cell survival by B cell-activating factor receptor of the TNF-R family
    Shinners, Nicholas P.
    Carlesso, Gianlllca
    Castro, Iris
    Hoek, Kristen L.
    Corn, Radiah A.
    Woodland, Robert L.
    Scott, Martin L.
    Wang, Demin
    Khan, Wasif N.
    JOURNAL OF IMMUNOLOGY, 2007, 179 (06) : 3872 - 3880
  • [37] The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21)
    Kuo, Sung-Hsin
    Tsai, Hui-Jen
    Lin, Chung-Wu
    Yeh, Kun-Huei
    Lee, Hsiao-Wei
    Wei, Ming-Feng
    Shun, Chia-Tung
    Wu, Ming-Shiang
    Hsu, Ping-Ning
    Chen, Li-Tzong
    Cheng, Ann-Lii
    JOURNAL OF PATHOLOGY, 2017, 241 (03) : 420 - 433
  • [38] Downregulation of microRNA-146a inhibits ovarian granulosa cell apoptosis by simultaneously targeting interleukin-1 receptor-associated kinase and tumor necrosis factor receptor-associated factor 6
    Chen, Xi
    Xie, Mingxuan
    Liu, Da
    Shi, Ke
    MOLECULAR MEDICINE REPORTS, 2015, 12 (04) : 5155 - 5162
  • [39] Caffeic Acid Inhibited Receptor Activator of Nuclear Factor KB Ligand (RANKL)Tumor Necrosis Factor (TNF) alpha-TNF Receptor Associated Factor (TRAF) 6 induced Osteoclastogenesis Pathway
    Sandra, Ferry
    Kukita, Toshio
    Muta, Tatsushi
    Iijima, Tadahiko
    INDONESIAN BIOMEDICAL JOURNAL, 2013, 5 (03): : 173 - 178
  • [40] Divergent Tumor Necrosis Factor Receptor-Related Remodeling Responses in Heart Failure Role of Nuclear Factor-κB and Inflammatory Activation
    Hamid, Tariq
    Gu, Yan
    Ortines, Roger V.
    Bhattacharya, Chhandashri
    Wang, Guangwu
    Xuan, Yu-Ting
    Prabhu, Sumanth D.
    CIRCULATION, 2009, 119 (10) : 1386 - 1397